OKLAHOMA CITY, OK--(Marketwired - Jan 10, 2017) - On January 6, 2017, a class action lawsuit was filed in the United States
District Court for the District of New Jersey against Agile Therapeutics, Inc. (NASDAQ: AGRX). The complaint alleges violations
of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations
of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the
market price during the Class Period, which is March 9, 2016 through January 3, 2017.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or
should you have any questions or concerns regarding this notice or preservation of your rights, please contact: Robin Hester,
FEDERMAN & SHERWOOD, 10205 North Pennsylvania Avenue, Oklahoma City, OK 73120, Email to: rkh@federmanlaw.com Or, visit the firm's website at www.federmanlaw.com
Plaintiff seeks to recover damages on behalf of all Agile Therapeutics, Inc. shareholders who purchased common stock during
the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Tuesday, March
7, 2017 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements
pursuant to the Private Securities Litigation Reform Act of 1995.